| 【Fixed Income Research】Power Construction Corp. of China New Issue |
| 【Company Research】Kintor Pharmaceutical (9939 HK) – Proxalutamide showed very promising efficacy signals in a Ph3 MRCT trial in COVID-19 outpatients |
| 【Fixed Income Research】INDYIJ – Solid FY2021 results; maintain Buy |
| 【Company Research】Great Wall Motor (2333 HK) – 1Q22 under pressure; less bumpy road ahead |
| 【Company Research】Vesync (2148 HK) – Higher development costs but better tariffs |
| 【Company Research】Venus Medtech (Hangzhou) Inc. (2500 HK) – Expanding global innovative product portfolio |
| 【Company Research】Weichai Power-A (000338 CH) – Short-term earnings under pressure; Import substitution strategy to support long-term earnings |
| 【Company Research】Weichai Power - H (2338 HK) – Short-term earnings under pressure; Import substitution strategy to support long-term earnings |
| 【Company Research】Sinotruk (Hong Kong) (3808 HK) – Expect earnings downside following weak results in 2H21; D/G to HOLD |
| 【Company Research】PSBC (1658 HK) – FY21 review: results in line, remains low exposure on property development industry |
公司地址：香港中環花園道三號冠君大廈45-46樓
電話：（852） 3900-0888 傳真：（852） 3761-8788
招銀國際版權所有 Copyright © 2019-2025 CMB International Capital Corporation Limited. All rights reserved.
